Fetal glucagon links fetal metabolism with uterine blood flow and placental nutrient transfer by inhibiting placental lactogen secretion
胎儿胰高血糖素通过抑制胎盘泌乳素分泌,将胎儿代谢与子宫血流和胎盘营养物质转移联系起来
基本信息
- 批准号:10636131
- 负责人:
- 金额:$ 66.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-13 至 2028-01-31
- 项目状态:未结题
- 来源:
- 关键词:AcidosisAmino AcidsArteriesBloodBlood flowCellsCirculationDataDiabetes MellitusDisease ManagementEndotheliumEnsureEventFetal DiseasesFetal GrowthFetal ProteinsFetal SheepFetal WeightFetusGlucagonGlucoseGoalsGrowthGrowth FactorHistologicHormonalHormonesHumanHypoxiaIn SituIn VitroInfusion proceduresInsulinInsulin-Like Growth Factor IInvestigationKnowledgeLinkMediatingMetabolicMetabolismMothersMyometrialNutrientNutritionalOxygenPhysiologicalPlacentaPlacental InsufficiencyPlacental LactogenPlacentationPlasmaPre-EclampsiaPregnancyPregnancy ComplicationsPregnant sheepProductionPublicationsRNA InterferenceRegulationRoleSheepSignal TransductionTechniquesTestingUterusVasodilator Agentseffective therapyexperimental studyfallsfetalfetus hypoxiain uteroinhibitorlentiviral-mediatedmaternal obesitynovelnutrient metabolismpreservationpreventrestorationtrophoblastuptake
项目摘要
PROJECT ABSTRACT
Our goal is to establish a new framework for understanding the regulation of fetal growth. To do so,
we will demonstrate novel roles for fetal glucagon and maternal placental lactogen. Current dogma
holds that the mother's nutritional and hormonal status, uterine blood flow, and early events in
placental development regulate placental nutrient delivery and fetal growth. However, knowledge
gaps in this understanding have prevented progress towards successful treatment of disordered fetal
growth during complications of pregnancy. This proposal will show how fetal glucagon inhibits uterine
blood flow and placental nutrient delivery by inhibiting secretion of placental lactogen into the
maternal circulation. We have recently demonstrated that experimentally increasing fetal glucagon
concentrations with direct fetal glucagon infusions into late gestation fetal sheep lowers uterine blood,
placental uptake of nutrients and oxygen from the maternal circulation, placental delivery of amino
acids to the fetus, fetal plasma concentrations of amino acids, fetal plasma concentrations of the
anabolic growth factors insulin and IGF-1, and fetal protein accretion. These were associated with a
13% reduction in fetal weight after just a nine-day infusion. Additionally, we have demonstrated that
experimentally lowering placental lactogen in pregnant sheep results in lower uterine blood flow and
placental nutrient delivery independent of its classically described role in regulating maternal nutrient
metabolism. We have repeatedly shown that increasing fetal amino acids raises fetal glucagon
concentrations. Taken together, these data support our overarching hypothesis: fetal glucagon
matches placental nutrient delivery to fetal metabolic demand by inhibiting PL secretion. This
hypothesis will be tested in pregnant sheep, isolated human primary trophoblasts, and uterine and
myometrial arteries isolated from pregnant sheep and humans, respectively. In Aim #1 we will show
that the mechanism by which fetal glucagon inhibits fetal growth is by lowering placental amino acid
delivery and fetal amino acid concentrations. In Aim #2 we will demonstrate that the mechanism by
which fetal glucagon inhibits uterine blood flow and placental nutrient delivery is by lowering placental
lactogen secretion. In Aim #3 we will establish the mechanism by which glucagon inhibits placental
lactogen secretion. This proposal will be the first mechanistic physiological investigation into fetal
glucagon as an inhibitor of uterine blood flow, placental nutrient delivery, and fetal growth and
placental lactogen as a vasodilator in the uterine circulation. The impact will be to shift the paradigm
for our understanding of the regulation of fetal growth. This is required if we are to make new
advances into the management of disordered fetal growth in pregnancies complicated by placental
insufficiency, preeclampsia, diabetes, maternal obesity and other conditions.
项目摘要
我们的目标是建立一个新的框架,了解胎儿生长的调节。要执行此操作,
我们将证明胎儿胰高血糖素和母体胎盘催乳素的新作用。现行教条
认为母亲的营养和激素状况、子宫血流以及妊娠早期事件
胎盘发育调节胎盘营养输送和胎儿生长。然而,知识
这种认识上的差距阻碍了成功治疗胎儿疾病的进展。
妊娠并发症期间的生长。这项建议将显示胎儿胰高血糖素如何抑制子宫内膜
通过抑制胎盘催乳素分泌到
母体循环我们最近证明,实验性增加胎儿胰高血糖素,
将胎儿胰高血糖素直接输注到妊娠晚期胎羊中的浓度降低了子宫血,
胎盘从母体循环中摄取营养和氧气,胎盘输送氨基
胎儿血浆氨基酸浓度、胎儿血浆氨基酸浓度、胎儿血浆
合成代谢生长因子胰岛素和IGF-1,以及胎儿蛋白质增加。这些都与一个
在九天的输液后胎儿体重减少了13%。此外,我们已经证明,
在怀孕绵羊中实验性地降低胎盘催乳素导致子宫血流量降低,
胎盘营养物质的输送与其在调节母体营养物质中的经典作用无关
新陈代谢.我们已经反复证明,增加胎儿氨基酸提高胎儿胰高血糖素
浓度的总之,这些数据支持我们的总体假设:胎儿胰高血糖素
通过抑制PL分泌使胎盘营养输送与胎儿代谢需求相匹配。这
将在妊娠绵羊、分离的人原代滋养层细胞和子宫和
分别从妊娠绵羊和人分离的子宫肌层动脉。在目标#1中,我们将展示
胎儿胰高血糖素抑制胎儿生长的机制是通过降低胎盘氨基酸
分娩和胎儿氨基酸浓度。在目标#2中,我们将通过以下方式证明该机制:
胎儿胰高血糖素抑制子宫血流和胎盘营养输送是通过降低胎盘
催乳素分泌在目标3中,我们将建立胰高血糖素抑制胎盘生长的机制。
催乳素分泌这一建议将是第一个机制的生理调查胎儿
胰高血糖素作为子宫血流、胎盘营养输送和胎儿生长的抑制剂,
胎盘催乳素在子宫循环中作为血管扩张剂。其影响将是改变范式
对我们了解胎儿生长的调节有很大帮助。这是必要的,如果我们要使新的
妊娠合并胎盘早剥胎儿生长障碍的处理进展
营养不足、先兆子痫、糖尿病、母体肥胖和其它病症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Paul Joseph Rozance其他文献
50 Years Ago in <em>T</em><span class="small-caps"><em>he</em></span> <em>J</em><span class="small-caps"><em>ournal of</em></span> <em>P</em><span class="small-caps"><em>ediatrics</em></span>: Perinatal Stress and the Premature Neonate. II. Effect of Fluid and Calorie Deprivation on Blood Glucose
- DOI:
10.1016/j.jpeds.2015.10.055 - 发表时间:
2016-03-01 - 期刊:
- 影响因子:
- 作者:
Paul Joseph Rozance - 通讯作者:
Paul Joseph Rozance
Paul Joseph Rozance的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Paul Joseph Rozance', 18)}}的其他基金
2016 Aspen/Snowmass Perinatal Biology Meeting
2016年阿斯本/斯诺马斯围产期生物学会议
- 批准号:
9050502 - 财政年份:2016
- 资助金额:
$ 66.12万 - 项目类别:
Nutrient Coordination of Pancreatic Vasculature and Beta-Cells
胰腺脉管系统和β细胞的营养协调
- 批准号:
8042046 - 财政年份:2011
- 资助金额:
$ 66.12万 - 项目类别:
Nutrient Coordination of Pancreatic Vasculature and Beta-Cells
胰腺脉管系统和β细胞的营养协调
- 批准号:
8316315 - 财政年份:2011
- 资助金额:
$ 66.12万 - 项目类别:
Nutrient Coordination of Pancreatic Vasculature and Beta-Cells
胰腺脉管系统和β细胞的营养协调
- 批准号:
8699189 - 财政年份:2011
- 资助金额:
$ 66.12万 - 项目类别:
Nutrient coordination of pancreatic vasculature and B-cells
胰腺血管系统和 B 细胞的营养协调
- 批准号:
9294069 - 财政年份:2011
- 资助金额:
$ 66.12万 - 项目类别:
Nutrient Coordination of Pancreatic Vasculature and Beta-Cells
胰腺脉管系统和β细胞的营养协调
- 批准号:
8871718 - 财政年份:2011
- 资助金额:
$ 66.12万 - 项目类别:
Nutrient Coordination of Pancreatic Vasculature and Beta-Cells
胰腺脉管系统和β细胞的营养协调
- 批准号:
8513983 - 财政年份:2011
- 资助金额:
$ 66.12万 - 项目类别:
Pancreatic beta-cell endothelial cell function and signaling in intrauterine grow
子宫内生长中的胰腺β细胞内皮细胞功能和信号传导
- 批准号:
8317629 - 财政年份:2009
- 资助金额:
$ 66.12万 - 项目类别:
Pancreatic beta-cell endothelial cell function and signaling in intrauterine grow
子宫内生长中的胰腺β细胞内皮细胞功能和信号传导
- 批准号:
7639887 - 财政年份:2009
- 资助金额:
$ 66.12万 - 项目类别:
Pancreatic beta-cell endothelial cell function and signaling in intrauterine grow
子宫内生长中的胰腺β细胞内皮细胞功能和信号传导
- 批准号:
8521330 - 财政年份:2009
- 资助金额:
$ 66.12万 - 项目类别:
相似海外基金
Double Incorporation of Non-Canonical Amino Acids in an Animal and its Application for Precise and Independent Optical Control of Two Target Genes
动物体内非规范氨基酸的双重掺入及其在两个靶基因精确独立光学控制中的应用
- 批准号:
BB/Y006380/1 - 财政年份:2024
- 资助金额:
$ 66.12万 - 项目类别:
Research Grant
Quantifying L-amino acids in Ryugu to constrain the source of L-amino acids in life on Earth
量化 Ryugu 中的 L-氨基酸以限制地球生命中 L-氨基酸的来源
- 批准号:
24K17112 - 财政年份:2024
- 资助金额:
$ 66.12万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Molecular recognition and enantioselective reaction of amino acids
氨基酸的分子识别和对映选择性反应
- 批准号:
23K04668 - 财政年份:2023
- 资助金额:
$ 66.12万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Basic research toward therapeutic strategies for stress-induced chronic pain with non-natural amino acids
非天然氨基酸治疗应激性慢性疼痛策略的基础研究
- 批准号:
23K06918 - 财政年份:2023
- 资助金额:
$ 66.12万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms how arrestins that modulate localization of glucose transporters are phosphorylated in response to amino acids
调节葡萄糖转运蛋白定位的抑制蛋白如何响应氨基酸而被磷酸化的分子机制
- 批准号:
23K05758 - 财政年份:2023
- 资助金额:
$ 66.12万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Design and Synthesis of Fluorescent Amino Acids: Novel Tools for Biological Imaging
荧光氨基酸的设计与合成:生物成像的新工具
- 批准号:
2888395 - 财政年份:2023
- 资助金额:
$ 66.12万 - 项目类别:
Studentship
Collaborative Research: RUI: Elucidating Design Rules for non-NRPS Incorporation of Amino Acids on Polyketide Scaffolds
合作研究:RUI:阐明聚酮化合物支架上非 NRPS 氨基酸掺入的设计规则
- 批准号:
2300890 - 财政年份:2023
- 资助金额:
$ 66.12万 - 项目类别:
Continuing Grant
Structurally engineered N-acyl amino acids for the treatment of NASH
用于治疗 NASH 的结构工程 N-酰基氨基酸
- 批准号:
10761044 - 财政年份:2023
- 资助金额:
$ 66.12万 - 项目类别:
Lifestyle, branched-chain amino acids, and cardiovascular risk factors: a randomized trial
生活方式、支链氨基酸和心血管危险因素:一项随机试验
- 批准号:
10728925 - 财政年份:2023
- 资助金额:
$ 66.12万 - 项目类别:
Single-molecule protein sequencing by barcoding of N-terminal amino acids
通过 N 端氨基酸条形码进行单分子蛋白质测序
- 批准号:
10757309 - 财政年份:2023
- 资助金额:
$ 66.12万 - 项目类别: